FindTrial
Sign In

Saphenus blok reduceerd opname duur na epifysiodese van de knie - een triple blind superiority trial

SaphenoUs Nerve block Reduces length of Stay after Epiphysiodesis of the knee-a triple blind randomized superiority trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22187
Enrollment
Unknown
Registered
2018-07-02
Start date
2018-09-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

We include 44 patients (22 verum 22 placebo) who have to ondergoe percutan epiphysiodesis of both knees under gerneal anesthesia. epifysiodese saphenus blok

Interventions

Single shot saphenous nerve block with either Ropivacaine or sodium chloride

Sponsors

Wilhelmina Ziekenhuis Assen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 12-18 yaers of age ASA 1 of 2 bilateral epiphysiodesis planned informed consent

Exclusion criteria

Exclusion criteria: ASA 3 or higher chronic pain chronic use of opiods refusal of the patient or care taker allergy to Ropivacaine abnormallity of the pheripheral nervous system concerning the femoral nerve and/ or the saphenous nerve inflammation of the distal third of the thigh

Design outcomes

Primary

MeasureTime frame
lenght of stay after surgery—

Secondary

MeasureTime frame
intra- and postoperative opiod consumption NRS pain scores time in the post anesthetic care unit time to walk (with crutches) strength of the quadriceps muscle overall patient satisfaction—

Contacts

Public ContactWilhelmina Ziekenhuis Assen Poli anesthesiologie
preop@wza.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)